The erythropoietin gene polymorphism (rs1617640) is associated with retinopathy in type 2 diabetes patients
Acta Diabetologica · 2026
DOI: 10.1007/s00592-026-02658-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, 2026. Verfasst von Jolanta Szeliga-Krol und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Medical University of Lublin, Jaczewskiego 8, 20-950, Lublin, Poland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Retinopathy, Erythropoietin, Polymorphism, Single Nucleotide. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS: Our study aimed to evaluate the association between the erythropoietin gene rs1617640 polymorphism and diabetic retinopathy (DR) in diabetes patients. METHODS: In this preliminary retrospective study the genotyping was performed on 860 DNA samples from Caucasian patients with type 2 diabetes mellitus (T2DM). For analyzing the effect of the polymorphism, patients were assigned into three phenotypic subgroups: non-DR (without retinopathy), NPDR (with non-proliferative diabetic retinopathy) and PDR (with proliferative diabetic retinopathy). The rs1617640 polymorphism was analyzed using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) and direct DNA sequencing procedures. RESULTS: A statistically significant difference in the polymorphism distribution was observed between T2DM patients with DR (both NPDR and PDR) and those without DR. The minor G allele was associated with the increased risk of DR. In the NPDR subgroup subjects carrying the G allele had 1.53-fold higher risk of developing retinopathy. Similarly, in the PDR subgroup patients carrying the G allele showed almost twofold increased risk of PDR in a dominant model of inheritance. CONCLUSION: Our results demonstrate that in T2DM patients the EPO rs1617460 polymorphism is associated with significantly increased risk of developing DR. This finding can provide a new insight into the role of EPO gene in the pathophysiology of microvascular complications of diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Medical University of Lublin, Jaczewskiego 8, 20-950, Lublin, Poland.
- Department of Nephrology, Medical University of Lublin, Jaczewskiego 8, 20-950, Lublin, Poland. monika.buraczynska@umlub.pl.
Zitieren
APA
Szeliga-Krol, J., Betlejewska, A., Buraczynska, M., & Zaluska, W. (2026). The erythropoietin gene polymorphism (rs1617640) is associated with retinopathy in type 2 diabetes patients. Acta Diabetologica. https://doi.org/10.1007/s00592-026-02658-9
Vancouver
Szeliga-Krol J, Betlejewska A, Buraczynska M, Zaluska W. The erythropoietin gene polymorphism (rs1617640) is associated with retinopathy in type 2 diabetes patients. Acta Diabetologica. 2026. doi:10.1007/s00592-026-02658-9
BibTeX
@article{SzeligaKrol2026,
author = {Szeliga-Krol, Jolanta and Betlejewska, Agata and Buraczynska, Monika and Zaluska, Wojciech},
title = {The erythropoietin gene polymorphism (rs1617640) is associated with retinopathy in type 2 diabetes patients},
journal = {Acta Diabetologica},
year = {2026},
doi = {10.1007/s00592-026-02658-9}
}
EUVIMED